GE, Roche partner to build digital diagnostics platform for oncology, critical care

Julie Spitzer - Print  | 

GE Healthcare and Roche partnered to develop a digital clinical decision support solution, focusing on products that accelerate and improve personalized cancer and critical care treatments, the companies said Monday.

As part of the agreement, the companies will work to build an analytics-enabled, digital platform that offers workflow solutions and apps supporting clinical decisions. The platform will allow integration and analysis of in-vivo and in-vitro data, patient records, medical best practice, real-time monitoring and the latest research outcomes.

"This is the first time that two major players in healthcare have combined advanced analytics with in-vivo and in-vitro diagnostics to this degree. We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients and the healthcare industry," said Kieran Murphy, president and CEO of GE Healthcare.

More articles on health IT:

Medical device supplier DJO Global notifies Las Vegas hospital of lost patient data

Bitcoin for teeth Dentacoin's value up 900% in 1 month

Philips, American Well team up in global telehealth venture

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.